Study of HRS-6213 in healthy people and cancer patients
Part of Cancer clinical trials.
This trial tests a new drug called HRS-6213. It is first given to healthy volunteers to check safety, and then to patients with solid tumors to see if it can help treat their cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be willing and able to follow the study plan and sign a consent form.
- For patients: have an ECOG performance status of 0 or 1 (able to carry out daily activities with little or no help).
- For patients: have a confirmed solid tumor that can be surgically removed or explored.
- For patients: have adequate organ function (heart, liver, kidneys, etc.).
- No severe allergies to the study drug or its ingredients.
- No serious heart problems (like heart failure, recent heart attack, or abnormal heart rhythm).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, HRS-7058, combined with other anti-cancer drugs for people with advanced solid tumors that cannot be surgically removed. The goal is to see if the combination can shrink tumors or slow their growth.
This is a phase 1 study testing a new oral drug called HRS-7058 for people with advanced solid tumors that have not responded to other treatments. The main goal is to find a safe dose and see how well the drug works.
This early study (Phase 1) tests whether HRS-1167 can be given safely to people with advanced solid tumors. It also looks for early signs of activity, especially in cancers with HRR gene mutations (like ovarian, breast, pancreatic, and prostate cancers).
This trial tests a new drug called HRS-4508 for people with advanced or metastatic solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe, how the body processes it, and if it helps shrink tumors.
This trial tests a new drug called HRS-6768 for people with advanced solid tumors that have stopped responding to standard treatments or have no good options. It aims to see if the drug is safe and effective.
This trial tests a new drug called HRS-7058 combined with other anti-tumor medicines for people with solid tumors. The goal is to see if the combination is safe and effective. It might be an option if you have advanced cancer and have not responded to other treatments.
Hear when a new Patients With Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.